Daniel Abdun-Nabi Insider Profile

4 Followers
Daniel Abdun-Nabi, CEO, Director at Emergent Biosolutions, holds 144.55K shares in Emergent Biosolutions (Ticker: EBS), holds ― shares in RegenXBio (Ticker: RGNX), holds 109.35K shares in Aptevo Therapeutics (Ticker: APVO).
tipranks
Daniel Abdun-Nabi

Daniel Abdun-Nabi
Emergent Biosolutions (EBS)
CEO, Director

Ranked #16,042 out of 78,624 Corporate Insiders

Profitable Transactions

44%
4 out of 9 Profitable Transactions

Average Return

+9.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$17M
71.15%
28.85%
0.00%
A breakdown of Daniel Abdun-Nabi's holdings

Insider Roles

Emergent Biosolutions
(EBS)
CEO, Director
Aptevo Therapeutics
(APVO)
Director
RegenXBio
(RGNX)
Director
Roles that Daniel Abdun-Nabi holds in companies

Most Profitable Insider Trade

Stock:
Emergent Biosolutions
(EBS)
Rating:Informative Buy
Date:Jan 12, 2017 - Jan 12, 2018
Return:+57.40%
The most profitable trade made by Daniel Abdun-Nabi

Daniel Abdun-Nabi's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Emergent Biosolutions
Mar 04, 2019
CEO, Director
Uninformative Sell
846.23K
$11.97M
RegenXBio
Director
Aptevo Therapeutics
Jun 25, 2019
Director
Informative Buy
15.00K
$4.85M
List of latest transactions for each holding click on a transaction to see Daniel Abdun-Nabi's performance on stock

Daniel Abdun-Nabi insider profile FAQ

What is the percentage of profitable transactions made by Daniel Abdun-Nabi?
The percentage of profitable transactions made by Daniel Abdun-Nabi is 44%.
    What is the average return per transaction made by Daniel Abdun-Nabi?
    The average return per transaction made by Daniel Abdun-Nabi is 9.40%.
      What stocks does Daniel Abdun-Nabi hold?
      Daniel Abdun-Nabi holds: EBS, RGNX, APVO stocks.
        What was Daniel Abdun-Nabi’s latest transaction?
        Daniel Abdun-Nabi latest transaction was an Uninformative Sell of $846.23K.
          What was Daniel Abdun-Nabi's most profitable transaction?
          Daniel Abdun-Nabi’s most profitable transaction was an Informative Buy of EBS stock on January 12, 2017. The return on the trade was 57.40%.
            What is Daniel Abdun-Nabi's role in Emergent Biosolutions?
            Daniel Abdun-Nabi's role in Emergent Biosolutions is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.